Calcipotriene and Betamethasone Dipropionate Ointment is a combination of calcipotriene hydrate, a synthetic vitamin D3 analogue, and betamethasone dipropionate, a synthetic corticosteroid. However, while their pharmacologic and clinical effects are known, the exact mechanisms of their actions in psoriasis vulgaris are unknown.
Sandoz will market this product in conjunction with Tolmar Inc., which owns the Abbreviated New Drug Application for Calcipotriene and Betamethasone Dipropionate Ointment. The product is available as a Calcipotriene 0.005% and Betamethasone Dipropionate 0.064% strength in 60g and 100g tubes.
For more information call (800) 525-8747 or visit Sandoz.com.